Vanda Pharmaceuticals (VNDA) Other Gross PP&E Adjustments (2016 - 2025)
Historic Other Gross PP&E Adjustments for Vanda Pharmaceuticals (VNDA) over the last 17 years, with Q3 2025 value amounting to -$6.8 million.
- Vanda Pharmaceuticals' Other Gross PP&E Adjustments rose 1216.53% to -$6.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.8 million, marking a year-over-year increase of 1216.53%. This contributed to the annual value of $8.1 million for FY2024, which is 3241.21% up from last year.
- As of Q3 2025, Vanda Pharmaceuticals' Other Gross PP&E Adjustments stood at -$6.8 million, which was up 1216.53% from -$8.7 million recorded in Q2 2025.
- Vanda Pharmaceuticals' 5-year Other Gross PP&E Adjustments high stood at $8.1 million for Q4 2024, and its period low was -$12.0 million during Q1 2024.
- Its 5-year average for Other Gross PP&E Adjustments is -$6.3 million, with a median of -$8.7 million in 2025.
- As far as peak fluctuations go, Vanda Pharmaceuticals' Other Gross PP&E Adjustments surged by 8873.9% in 2021, and later tumbled by 2992.2% in 2024.
- Quarter analysis of 5 years shows Vanda Pharmaceuticals' Other Gross PP&E Adjustments stood at $3.2 million in 2021, then surged by 42.7% to $4.6 million in 2022, then surged by 33.17% to $6.1 million in 2023, then skyrocketed by 32.41% to $8.1 million in 2024, then tumbled by 184.27% to -$6.8 million in 2025.
- Its Other Gross PP&E Adjustments was -$6.8 million in Q3 2025, compared to -$8.7 million in Q2 2025 and -$10.5 million in Q1 2025.